Press Release

Jan, 04 2024

Exploring the Diversity of Products in the Dynamic Point-of-Care Testing (POCT) Market

The point-of-care testing (POCT) market offers diverse products catering to immediate diagnostic needs. This includes glucose monitoring, cardiometabolic testing, infectious diseases testing, pregnancy and fertility testing, tumor/cancer marker testing, urinalysis testing, cholesterol testing, hematology testing, drug-of-abuse testing, fecal occult testing, rapid coagulation testing, and various other POC products. Each category addresses specific health concerns, contributing to the market's ability to provide rapid and convenient diagnostic solutions across various medical applications.

Access Full Report @

Data Bridge Market Research analyses that the Thailand Point-of-Care Testing (POCT) Market, which was USD 139.18 million in 2022, would reach up to USD 251.94 million by 2030, and is expected to undergo a CAGR of 7.70% during the forecast period of 2023-2030. remote and underserved areas are a significant driver in the point-of-care testing (POCT) market. POCT brings diagnostic services to areas with limited healthcare access, ensuring swift and efficient testing. This accessibility enhances healthcare delivery, especially in remote and underserved regions, addressing critical medical needs and improving overall health outcomes.

Key Findings of the Study

Thailand Point-of-Care Testing (POCT) Market

Growing chronic diseases are expected to drive the market's growth rate

The escalating prevalence of chronic diseases fuels demand for on-the-spot diagnostic solutions, positioning it as a key driver in the point-of-care testing (POCT) market. POCT offers immediate testing capabilities, enabling timely disease detection and management. With a rising global burden of chronic conditions, including diabetes and cardiovascular diseases, the demand for rapid, accessible, and accurate diagnostic tools becomes paramount, driving the adoption of POCT technologies for effective disease monitoring and improved patient outcomes.

Report Scope and Market Segmentation

Report Metric


Forecast Period

2023 to 2030

Base Year


Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Products (Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Diseases Testing Products, Pregnancy and Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-of-Abuse Testing Products, Fecal Occult Testing Products, Rapid Coagulation Testing, and other POC Products),  Application (Blood Glucose Cardiac Monitoring, Hematology, Coagulation, Whole Blood Analysis, Vital Sign Monitoring, Non-Invasive Spo2 Monitoring, Non-Invasive Pco2 Monitoring, Blood Transfusion, and Others), Platform (Lateral Flow Assays/Immunochromatography Tests, Dipsticks, Molecular Diagnostics, Immunoassays, and Microfluidics), Prescription Mode (Prescription Based Testing and OTC Testing), Testing Type (Immunoassays, Cell-Based Assays, Nucleic Acid Amplification Testing, Clinical Chemistry Assays, and Hematology), End-Users Segment (Hospitals, Clinics, Laboratories, Home Care, Ambulatory Surgical Centers, Others),  Distribution Channel (Direct and Retail Pharmacies)

Market Players Covered

Bio-Rad Laboratories, Inc. (U.S.), bioMérieux SA (France), Trinity Biotech (Ireland), BD (U.S.), EKF Diagnostics (U.K.), Abbott (U.S.), Quidel Corporation (U.S.), Sienco, Inc. (U.S.), Danaher (U.S.), Chembio Diagnostics Systems, Inc. (U.S.), Nova Biomedical (U.S.), PTS Diagnostics (U.S.), AccuBioTech Co., Ltd (China), Beckman Coulter, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Sekisui Diagnostics (Japan), Instrumentation Laboratory (A Subsidiary Of Werfen) (U.S.), Xiamen Biotime Biotechnology Co., Ltd. (China), FUJIFILM Thailand Ltd. (Thailand)

Data Points Covered in the Report

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Segment Analysis:

The Thailand point-of-care testing (POCT) market is segmented on the basis of products, application, platform, prescription mode, testing type, end-users, and distribution channel.

  • On the basis of products, the Thailand point-of-care testing (POCT) market is segmented into glucose monitoring products, cardiometabolic testing products, infectious diseases testing products, pregnancy and fertility testing products, tumor/cancer marker testing products, urinalysis testing products, cholesterol testing products, hematology testing products, drug-of-abuse testing products, fecal occult testing products, rapid coagulation testing, and other POC product
  • On the basis of application, the Thailand point-of-care testing (POCT) market is segmented into blood glucose cardiac monitoring, hematology, coagulation, whole blood analysis, vital sign monitoring, non-invasive Spo2 monitoring, non-invasive Pco2 monitoring, blood transfusion, and others
  • On the basis of platform, the Thailand point-of-care testing (POCT) market is segmented into lateral flow assays/immunochromatography tests, dipsticks, molecular diagnostics, immunoassays, and microfluidics
  • On the basis of prescription mode, the Thailand point-of-care testing (POCT) market is segmented into prescription based testing and OTC testing
  • On the basis of testing type, the Thailand point-of-care testing (POCT) market is segmented into immunoassays, cell-based assays, nucleic acid amplification testing, clinical chemistry assays, and hematology
  • On the basis of end-users, the Thailand point-of-care testing (POCT) market is segmented into hospitals, clinics, laboratories, home care, ambulatory surgical centers, and others
  • On the basis of distribution channel, the Thailand point-of-care testing (POCT) market is segmented into direct and retail pharmacies

Major Players

Data Bridge Market Research recognizes the following companies as the Thailand point-of-care testing (POCT) market players in Thailand point-of-care testing (POCT) market are Bio-Rad Laboratories, Inc. (U.S.), bioMérieux SA (France), Trinity Biotech (Ireland), BD (U.S.), EKF Diagnostics (U.K.), Abbott (U.S.), Quidel Corporation (U.S.), Sienco, Inc. (U.S.).

Thailand Point-of-Care Testing (POCT) Market

Market Developments

  • In 2023, Trinity Biotech collabrated with imaware to create at-home and remote point-of-care rapid testing solutions. Leveraging Trinity Biotech's manufacturing expertise, the collaboration focuses on developing integrated white-label and private solutions for digital health channel partners. The goal is to offer industry-leading turnaround times and seamlessly integrate a patient-centric ecosystem, addressing the evolving needs of point-of-care diagnostics in the digital health landscape
  • In 2022, Una Health revealed a strategic partnership with Siemens Healthineers to broaden the distribution channel for the Atellica VTLi Patient-side Immunoassay Analyzer in the U.K. This partnership aims to optimize the availability of advanced diagnostic technology, specifically the Atellica VTLi Analyzer, facilitating improved patient care and diagnostic capabilities across the United Kingdom through a strengthened distribution network established by the partnership
  • In 2022, Nova Biomedical launched the CE-Marked Nova Max Pro Creatinine/eGFR Meter, a kidney function screening tool. Designed for point-of-care settings, this innovation enables early detection of kidney diseases, enhancing kidney care outcomes. The meter's launch signifies Nova Biomedical's commitment to advancing healthcare solutions, providing a valuable tool for efficient and timely monitoring of kidney function, ultimately contributing to improved patient outcomes in the field of nephrology
  • In 2022, Zoetis expanded its digital precision animal health portfolio by introducing BLOCKYARD and Performance Ranch. These innovative additions leverage blockchain technology to offer comprehensive information on cattle health. Accessible remotely through digital devices, Zoetis aims to enhance livestock management, providing farmers with real-time insights to optimize health, performance, and overall well-being of their cattle, marking a significant advancement in precision animal health
  • In 2020, Beckman Coulter, Inc. launched an innovative total laboratory automation solution, redefining turnaround time standards. The system aims to enhance result quality and streamline laboratory operations. By setting new benchmarks in service quality, Beckman Coulter positions itself for increased revenue in the future. This strategic introduction reflects the company's commitment to advancing laboratory technology, providing efficient solutions, and maintaining a competitive edge in the diagnostics and healthcare industry

For more detailed information about the Thailand point-of-care testing (POCT) market report, click here –

Client Testimonials